Kenkare-Mitra Sara
President and Head of R&D
Kenkare-Mitra Sara has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Dec 3, 2025.
On the most recent filing, Kenkare-Mitra Sara is listed as President and Head of R&D at Alector, Inc. Inside the rolling window, Kenkare-Mitra Sara reported no open-market purchases and 1 open-market sale totaling $47K in ALEC.
Companies traded
Other insiders at ALEC
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$47K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 2, 2025 | ALEC | Sale | $59K |
Frequently asked questions
How many SEC Form 4 filings has Kenkare-Mitra Sara made?
Kenkare-Mitra Sara has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2025.
Which companies does Kenkare-Mitra Sara trade?
Kenkare-Mitra Sara has filed SEC Form 4 disclosures for 1 company, including ALEC.
When was Kenkare-Mitra Sara's most recent SEC Form 4 filing?
Kenkare-Mitra Sara's most recent SEC Form 4 filing on Tracefour is dated Dec 3, 2025.
What is Kenkare-Mitra Sara's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Kenkare-Mitra Sara is listed as President and Head of R&D.
What is Kenkare-Mitra Sara's total buy and sell value in the current window?
Inside the rolling retention window, Kenkare-Mitra Sara bought $0 and sold $47K based on SEC Form 4 filings.
What was Kenkare-Mitra Sara's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 41,687 ALEC shares on 2025-12-03, worth $47K, per SEC Form 4 filings.